Clinical Study

Gestational Diabetes Mellitus: Screening and Outcomes in Southern Italian Pregnant Women

Table 2

 (a) Outcomes in women <35 years old, without risk factors for GDM. (b) Outcomes in newborns of women <35 years old, without risk factors for GDM.
(a)

OutcomeGDM ( )No GDM ( )OR (95% CI) valueOR (95% CI)a valueaPower (%)

Primary cesarean section, (%)51 (29.8)56 (15.3)2.36 (1.53–3.64)<0.0011.92 (1.21–3.06)0.006>95
Secondary cesarean section, (%)19 (11.1)12 (3.7)3.97 (1.80–8.77)0.0015.05 (2.11–12.08)<0.00185.3
Cesarean section after labor, (%)3 (1.8)10 (2.7)0.64 (0.17–2.35)0.4980.55 (0.14–2.21)0.4019.6
Labor induction, (%)2 (1.2)1 (0.3)4.33 (0.39–48.10)0.2333.85 (0.28–53.29)0.31413.6
Gestosis manifestations, (%)12 (7.0)11 (3.0)2.44 (1.05–5.65)0.0372.03 (0.83–4.97)0.12048.7
Hypertension, (%)7 (4.1)6 (1.6)2.57 (0.85–7.76)0.0951.73 (0.70–7.16)0.17333.5
Preeclampsia, (%)5 (2.9)5 (1.4)2.18 (0.62–7.63)0.2231.70 (0.44–6.65)0.44318.2
Fetal distress, (%)5 (2.9)10 (2.7)1.07 (0.36–3.20)0.8960.91 (0.28–3.00)0.8798
Polyhydramnios, (%)8 (4.7)4 (1.1)4.45 (1.32–15.0)0.0164.48 (1.20–16.73)0.02558.8
Oligohydramnios, (%)4 (2.4)3 (0.8)2.91 (0.64–13.13)0.1661.65 (0.32–8.51)0.54928.6
Preterm delivery, (%)14 (8.2)13 (3.5)2.43 (1.11–5.29)0.0251.94 (0.84–4.48)0.11852.4
Breech presentation, (%)18 (10.5)31 (8.4)1.23 (0.67–2.26)0.5021.24 (0.65–2.21)0.5639.9

OR: odds ratio; CI: confidence interval.
aValues were adjusted for maternal age, pregravidic BMI, and parity.
Power has been post hoc calculated with G*Power 3.1, entering -squared multiple correlation coefficient obtained with regression for each trait.
(b)

OutcomeGDM
( )
No GDM
( )
OR (95% CI) valueOR (95% CI) valuePower (%)

Birth weight (Kg), mean ± SD (median)
(3.3)

(3.1)
0.002a<0.001b>95
Serious perinatal complications, (%)20 (11.7)32 (8.7)1.47 (0.82–2.63)0.1991.24 (0.66–2.33) c0.497c17.3
Dystocia, (%)0 (0.0)1 (0.3)
Bone fracture, (%)2 (1.2)0 (0.0)
Admission to NICU, (%)11 (6.4)6 (1.6)4.14 (1.50–11.38)0.0064.39 (1.44–13.37)d0.009d68.6
RDS, (%)3 (1.8)2 (0.5)3.26 (0.54–19.69)0.1982.66 (0.41–17.44)e0.307e26.4
TTN, (%)4 (2.4)3 (0.8)2.91 (0.64–13.13)0.1661.89 (0.33–10.70)e0.472e27.9
Macrosomy (≥4 Kg), (%)2 (1.2)6 (1.6)1.44 (0.24–8.67)0.6930.48 (0.86–2.70)c0.481c28.6
LGA, (%)15 (8.8)7 (1.9)4.94 (1.98–12.37)<0.0013.53 (1.34–9.34)c0.011c85.6
SGA, (%)5 (2.9)6 (1.6)1.81 (0.54–6.02)0.3321.98 (0.53–7.41)c0.312c16.6
Metabolic complications, (%)9 (5.3)7 (1.9)2.86 (1.05–7.80)0.0412.32 (0.76–7.06)c0.137c46.6
Hypoglycaemia, (%)1 (0.6)0 (0.0)
Hyperbilirubinemia, (%)4 (2.4)3 (0.8)2.91 (0.64–13.13)0.1661.19 (0.24–5.84)c0.826c28.5
Hypocalcemia, (%)2 (1.2)2 (0.5)2.16 (0.30–15.46)0.4435.28 (0.67–41.37)c0.113c15.4
Polycythemia, (%)2 (1.2)2 (0.5)2.16 (0.30–15.46)0.4432.19 (0.26–18.69)c0.474c15.4

Calculated with Mann-Whitney test. bCalculated by linear regression analysis after adjustment for maternal age, pregravidic BMI, and gestational age at birth. cValues were obtained with logistic regression analysis after adjustment for maternal age, pregravidic BMI, parity, and gestational age at birth. dValues were obtained with logistic regression analysis after adjustment for maternal age, pregravidic BMI, parity, and neonatal weight. eValues were obtained with logistic regression after adjustment for maternal age, pregravidic BMI, parity, and mode of delivery. NICU: neonatal intensive care unit; RDS: respiratory distress syndrome; TTN: transient tachypnea of newborn; LGA: large for gestational age; SGA: small for gestational. Power has been post hoc calculated with G*Power 3.1, entering -squared multiple correlation coefficient obtained with regression for each trait.